סומטולין אוטוג'ל 60 מג
medison pharma ltd - lanreotide as acetate - תמיסה להזרקה - lanreotide as acetate 60 mg/dose - lanreotide - lanreotide - somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of growth hormone (gh) and/or insulin like growth factor-1 (igf-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .the goal of treatment in acromegaly is to reduce gh and igf-1 levels and where possible to normalize these values. somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.
סומטולין אוטוג'ל 90 מג
medison pharma ltd - lanreotide as acetate - תמיסה להזרקה - lanreotide as acetate 90 mg/dose - lanreotide - lanreotide - somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of growth hormone (gh) and/or insulin like growth factor-1 (igf-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .the goal of treatment in acromegaly is to reduce gh and igf-1 levels and where possible to normalize these values. somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.
סומטולין אוטוג'ל 120 מג
medison pharma ltd - lanreotide as acetate - תמיסה להזרקה - lanreotide as acetate 120 mg/dose - lanreotide - lanreotide - somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of growth hormone (gh) and/or insulin like growth factor-1 (igf-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .the goal of treatment in acromegaly is to reduce gh and igf-1 levels and where possible to normalize these values. somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.
קבומטיקס 20 מג
medison pharma ltd - cabozantinib as (s) malate - טבליות מצופות פילם - cabozantinib as (s) malate 20 mg - cabozantinib
קבומטיקס 40 מג
medison pharma ltd - cabozantinib as (s) malate - טבליות מצופות פילם - cabozantinib as (s) malate 40 mg - cabozantinib
קבומטיקס 60 מג
medison pharma ltd - cabozantinib as (s) malate - טבליות מצופות פילם - cabozantinib as (s) malate 60 mg - cabozantinib
אינקרלקס
medison pharma ltd - mecasermin - תמיסה להזרקה - mecasermin 10 mg / 1 ml - mecasermin
סומטולין ש.מ. 30 מג
medison pharma ltd - lanreotide acetate - אבקה וממס להכנת תרחיף להזרקה - lanreotide acetate 0.03 g/vial - lanreotide - lanreotide - treatment of acromegaly (when the treatment of growth hormone is not normalized after surgery and/or radiotherapy). treatment of the clinical symptoms of carcinoid tumors (after a test injection). treatment of primary thyrotropic adenomas responsible for hypethyroidism as a preparation for / or as a complement to surgery and/or radiotherapy or where these therapies are unsuitable.
דיפרילין 3.75 מג
medison pharma ltd - triptorelin as acetate - אבקה וממס להכנת תרחיף להזרקה - triptorelin as acetate 3.75 mg/vial - triptorelin - triptorelin - prostate cancer: treatment of prostate cancer with metastases. patients who have not previously received hormone therapy show a more marked response to the treatment and respond more frequently if the patient has not previously receieved another hormone treatment. precocious puberty: (before 8 years in girls and 10 years in boys). genital and extragenital endometriosis (stage i to stage iv): treatment should not be administered for more than 6 months. it is not recomended to start a second treatment course with triptorelin or another gnrh analogue. treatment of uterine fibromyomas prior to surgery: associated with anaemia ( haemoglobin less than, or equal to 8 g/dl). when a reduction in the size of the fibromyoma is necessary to facilitate or modify the surgical technique: endoscopic surgery, transvaginal surgery. the treatment duration is restricted to 3 months. female infertility: supplementary treatment in combination with gonadotrophins (hmg, fsh, hcg) to induce ovulation with a view to in vitro fertilisa
דיפרלין 0.1 מג
medison pharma ltd - triptorelin as acetate - אבקה וממס להכנת תמיסה להזרקה - triptorelin as acetate 0.1 mg/vial - triptorelin - triptorelin - female infertility: management of ovarian stimulation in association with the gonadotrophins (hmg, fsh, hcg) in view of in vitro fertilisation and embrio transfer (i.v.f.e.t.) and other assisted conception techniques.